做多
PRVB Breakout Stock Alert
BREAKOUT STOCK ALERT
PPRVB - Provention Bio, Inc. - Common Stock
Initial Alert Price: $15.31
Potential Price: $19.19
Potential Gains: 25.34
Stop Loss Limit: $
Placing a position on PRVB for a potential 25-30% Swing on the Trade after the stock completed a reversal from it's most recent breakout to the $20.05. The stock broke out from trading around the $13-$14 Price Ranges back in December after announcing that the company would be initiating its First-In-Human Study of Coxsackievirus B Vaccine Candidate PRV-101. The reached $20.05 at its high before the company announced a proposed offer of 6M Public Shares of Common Stock and then another $100M Public Offering on Jan. 14th in order to access more liquidity. We will be looking for the stock to break above the most recent levels of support before the offerings around the $16.60's and then continue to move forward retesting the $19.19's and above over the course of the next few trading sessions. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
PPRVB - Provention Bio, Inc. - Common Stock
Initial Alert Price: $15.31
Potential Price: $19.19
Potential Gains: 25.34
Stop Loss Limit: $
Placing a position on PRVB for a potential 25-30% Swing on the Trade after the stock completed a reversal from it's most recent breakout to the $20.05. The stock broke out from trading around the $13-$14 Price Ranges back in December after announcing that the company would be initiating its First-In-Human Study of Coxsackievirus B Vaccine Candidate PRV-101. The reached $20.05 at its high before the company announced a proposed offer of 6M Public Shares of Common Stock and then another $100M Public Offering on Jan. 14th in order to access more liquidity. We will be looking for the stock to break above the most recent levels of support before the offerings around the $16.60's and then continue to move forward retesting the $19.19's and above over the course of the next few trading sessions. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。